LabCentral Golden Ticket
Forecasted
Roche’s LabCentral Golden Ticket grants an early-stage biotech startup a year of free lab space at LabCentral Boston to accelerate scientific research and innovation.
Funder: Roche
Due Dates (Anticipated): December 2026
Funding Amounts: One year of free lab space at LabCentral (Boston); covers all lab space costs for 12 months for one winning company.
Summary: Provides early-stage biotech startups with a year of complimentary lab space at LabCentral to accelerate research and innovation.
Key Information: For early-stage biotech companies only; award is in-kind (lab space), not cash.
Description
The LabCentral Golden Ticket, sponsored by Roche, offers one early-stage biotech company a full year of free lab space at LabCentral in Boston. This initiative is designed to support innovative biotech startups by providing access to state-of-the-art laboratory facilities and a vibrant, collaborative scientific community. The program aims to accelerate scientific breakthroughs by removing the barrier of lab space costs and enabling startups to focus on advancing their research and development.
